Suppr超能文献

危重病患者的氧疗:精确控制动脉血氧和允许性低氧血症。

Oxygen therapy in critical illness: precise control of arterial oxygenation and permissive hypoxemia.

机构信息

UCL Centre for Altitude, Space and Extreme Environment Medicine, Portex Unit, Institute of Child Health, London, United Kingdom.

出版信息

Crit Care Med. 2013 Feb;41(2):423-32. doi: 10.1097/CCM.0b013e31826a44f6.

Abstract

OBJECTIVE

The management of hypoxemia in critically ill patients is challenging. Whilst the harms of tissue hypoxia are well recognized, the possibility of harm from excess oxygen administration, or other interventions targeted at mitigating hypoxemia, may be inadequately appreciated. The benefits of attempting to fully reverse arterial hypoxemia may be outweighed by the harms associated with high concentrations of supplemental oxygen and invasive mechanical ventilation strategies. We propose two novel related strategies for the management of hypoxemia in critically ill patients. First, we describe precise control of arterial oxygenation involving the specific targeting of arterial partial pressure of oxygen or arterial hemoglobin oxygen saturation to individualized target values, with the avoidance of significant variation from these levels. The aim of precise control of arterial oxygenation is to avoid the harms associated with inadvertent hyperoxia or hypoxia through careful and precise control of arterial oxygen levels. Secondly, we describe permissive hypoxemia: the acceptance of levels of arterial oxygenation lower than is conventionally tolerated in patients. The aim of permissive hypoxemia is to minimize the possible harms caused by restoration of normoxemia while avoiding tissue hypoxia. This review sets out to discuss the strengths and limitations of precise control of arterial oxygenation and permissive hypoxemia as candidate management strategies in hypoxemic critically ill patients.

DESIGN

We searched PubMed for references to "permissive hypoxemia/hypoxaemia" and "precise control of arterial oxygenation" as well as reference to "profound hypoxemia/hypoxaemia/hypoxia," "severe hypoxemia/hypoxaemia/hypoxia." We searched personal reference libraries in the areas of critical illness and high altitude physiology and medicine. We also identified large clinical studies in patients with critical illness characterized by hypoxemia such as acute respiratory distress syndrome.

SUBJECTS

Studies were selected that explored the physiology of hypoxemia in healthy volunteers or critically ill patients.

SETTING

The data were subjectively assessed and combined to generate the narrative.

RESULTS

Inadequate tissue oxygenation and excessive oxygen administration can be detrimental to outcome but safety thresholds lack definition in critically ill patients. Precise control of arterial oxygenation provides a rational approach to the management of arterial oxygenation that reflects recent clinical developments in other settings. Permissive hypoxemia is a concept that is untested clinically and requires robust investigation prior to consideration of implementation. Both strategies will require accurate monitoring of oxygen administration and arterial oxygenation. Effective, reliable measurement of tissue oxygenation along with the use of selected biomarkers to identify suitable candidates and monitor harm will aid the development of permissive hypoxemia as viable clinical strategy.

CONCLUSIONS

Implementation of precise control of arterial oxygenation may avoid the harms associated with excessive and inadequate oxygenation. However, at present there is no direct evidence to support the immediate implementation of permissive hypoxemia and a comprehensive evaluation of its value in critically ill patients should be a high research priority.

摘要

目的

危重病患者的低氧血症管理具有挑战性。虽然组织缺氧的危害已得到充分认识,但过度供氧或其他旨在减轻低氧血症的干预措施可能会被低估。试图完全逆转动脉低氧血症的益处可能会被与高浓度补充氧气和有创机械通气策略相关的危害所抵消。我们提出了两种治疗危重病患者低氧血症的新策略。首先,我们描述了动脉氧合的精确控制,包括动脉血氧分压或动脉血红蛋白氧饱和度的特定靶向到个体化目标值,避免这些水平的显著变化。动脉氧合精确控制的目的是通过仔细和精确地控制动脉氧水平来避免与意外高氧血症或低氧血症相关的危害。其次,我们描述了允许性低氧血症:接受传统上可耐受的患者较低的动脉氧合水平。允许性低氧血症的目的是在避免组织缺氧的同时,尽量减少恢复正常氧合引起的可能危害。本综述旨在讨论动脉氧合精确控制和允许性低氧血症作为低氧血症危重病患者候选治疗策略的优缺点。

设计

我们在 PubMed 上搜索了“允许性低氧血症/低氧血症”和“动脉氧合的精确控制”以及“严重低氧血症/低氧血症/缺氧”、“严重低氧血症/低氧血症/缺氧”的参考文献。我们在危重病和高原生理学和医学领域搜索了个人参考资料。我们还确定了一些大型临床试验,这些试验涉及到急性呼吸窘迫综合征等低氧血症的危重病患者。

对象

选择了探索健康志愿者或危重病患者低氧血症生理学的研究。

地点

对数据进行了主观评估,并结合起来生成了叙述。

结果

组织供氧不足和过度供氧都可能对预后产生不利影响,但危重病患者的安全阈值缺乏定义。动脉氧合的精确控制为管理动脉氧合提供了一种合理的方法,反映了其他领域最近的临床发展。允许性低氧血症是一个尚未在临床上得到验证的概念,在考虑实施之前需要进行严格的调查。这两种策略都需要准确监测氧气的给予和动脉氧合。有效的、可靠的氧输送监测以及使用选定的生物标志物来识别合适的候选者和监测危害将有助于允许性低氧血症作为一种可行的临床策略的发展。

结论

实施动脉氧合的精确控制可能避免与过度和供氧不足相关的危害。然而,目前没有直接证据支持立即实施允许性低氧血症,对其在危重病患者中的价值进行全面评估应成为一个高度优先的研究重点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验